title: Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and disease.
abstract: Several cutaneous inflammatory diseases and their clinical phenotypes are recapitulated in animal models of skin disease. However, the identification of shared pathways for disease progression is limited by the ability to delineate the complex biochemical processes fundamental for development of the disease. Identifying common signaling pathways that contribute to cutaneous inflammation and immune function will facilitate better scientific and therapeutic strategies to span a variety of inflammatory skin diseases. Aberrant antimicrobial peptide (AMP) expression and activity is one mechanism behind the development and severity of several inflammatory skin diseases and directly influences the susceptibility of skin to microbial infections. Our studies have recently exposed a newly identified pathway for negative regulation of AMPs in the skin by the cholinergic anti-inflammatory pathway via acetylcholine (ACh). The role of ACh in AMP regulation of immune and permeability barrier function in keratinocytes is reviewed, and the importance for a better comprehension of cutaneous disease progression by cholinergic signaling is discussed.
authors.affiliation: Department of Surgery, Loyola University Medical Center, Burn and Shock Trauma Institute, Maywood, Illinois 60153, USA.
authors.forename: Brenda J
authors.initials: BJ
authors.lastname: Curtis
authors.forename: Katherine A
authors.initials: KA
authors.lastname: Radek
mesh_terms: D000109:Acetylcholine / Q000276:immunology*; D000078404:Epidermal Cells; D004817:Epidermis / Q000276:immunology*; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology*; D015603:Keratinocytes / Q000276:immunology* / Q000378:metabolism; D010539:Permeability; D012871:Skin Diseases / Q000276:immunology* / Q000378:metabolism
chemical_list: D000109:Acetylcholine